Free Trial

Journey Medical (DERM) Earnings Date, Estimates & Call Transcripts

Journey Medical logo
$5.65 -0.06 (-1.05%)
(As of 11/8/2024 ET)

Journey Medical Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 12Estimated
Actual EPS
(Aug. 12)
-$0.17 Missed By -$0.03
Consensus EPS
(Aug. 12)
-$0.14

Journey Medical announced Q2 2024 earnings on August 12, 2024, reporting an EPS of -$0.17, which missed the consensus estimate of -$0.14 by $0.03. Quarterly revenue was reported to be $14.86 million, above analysts' expectations of $13.81 million. With a trailing EPS of -$0.02, Journey Medical's earnings are expected to grow next year, from ($1.03) to ($0.18) per share.

DERM Upcoming Earnings

Journey Medical's next earnings date is estimated for Tuesday, November 12, 2024, based off prior year's reporting schedules.

Get Journey Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Journey Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DERM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DERM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Journey Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.21-$0.21-$0.21
Q4 20242-$0.21-$0.12-$0.17
20243-$0.42-$0.33-$0.38
Q3 20251$0.20$0.20$0.20
Q4 20251$0.32$0.32$0.32

Journey Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Estimated)
------- 
8/12/2024Q2 2024-$0.14-$0.17 -$0.03-$0.17$13.81M$14.86M      
5/13/2024Q1 2024-$0.26-$0.53 -$0.27-$0.53$14.91M$13.03M  
3/21/2024Q4 2023--$0.12 -$0.12-$0.12$15.80M$15.26M  
11/7/2023Q3 2023-$0.16$0.80+$0.96$0.80$16.88M$34.54M  
8/8/2023Q2 2023-$0.34-$0.46 -$0.12-$0.46$14.81M$17.17M  
5/22/2023Q1 2023-$0.44-$0.57 -$0.13-$0.57$15.87M$12.21M  
3/29/2023Q4 2022-$0.37-$0.60 -$0.23-$0.60$16.67M$15.97M  
11/10/2022Q3 2022-$0.34-$0.57 -$0.23-$0.57$18.23M$16.12M  

Journey Medical Earnings - Frequently Asked Questions

Journey Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates. Learn more on DERM's earnings history.

In the previous quarter, Journey Medical (NASDAQ:DERM) missed the analysts' consensus estimate of ($0.14) by $0.03 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. DERM's actual earnings.

The conference call for Journey Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Journey Medical's latest earnings report can be read online.
Read Transcript

Journey Medical (NASDAQ:DERM) has a recorded annual revenue of $77.68 million.

Journey Medical (NASDAQ:DERM) has a recorded net income of -$3.85 million. DERM has generated -$0.02 earnings per share over the last four quarters.

Journey Medical's earnings are expected to grow from ($1.03) per share to ($0.18) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:DERM) was last updated on 11/10/2024 by MarketBeat.com Staff
From Our Partners